In the case of NMDAR1-AB, the AB act ketamine-like, display “effects and side effects” – some advantageous (e.g., antidepressive, stroke lesion-reducing [1, 14]), others unwanted (inducing psychosis or promoting dementia [12, 15–17]) – just as with pharmacological treatments. Here, GRIN1 is linked to dementia.